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1. Introduction 
Microspheres constitute an important part of drug delivery systems by virtue of their small size and efficient 
carrier characteristics. A well designed controlled drug delivery system can overcome some of the problems of 
conventional therapy and enhance the therapeutic efficacy of a given drug. One such approach is using microspheres as 
carriers for drugs. It is the reliable means to deliver the drug to the target site with specificity, if modified, and to maintain 
the desired concentration at the site of interest without untoward effects.[1-2]  
They are made up of polymeric, waxy, or other protective materials that are like synthetic biodegradable polymer 
and modified natural products such as starches, gums, proteins, fats and waxes. Such designed microspheres incorporating 
a drug dispersed or dissolved throughout the particle matrix have the potential for the controlled release. 
Mucoadhesion is commonly defined as the adhesion between two materials, at least one of which is a mucosal 
surface. Mucoadhesive dosage forms may be designed to enable prolonged retention at the site of application, providing a 
controlled rate of drug release for improved therapeutic outcome.[3-7] 
Type 2 diabetes mellitus (T2DM) is the most common form of diabetes constituting 90% of the diabetic 
population. The number of patients with diabetes in India is currently around 40.9 million and is expected to rise to 101 
million by 2030.[8] 
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus 
(NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the 
pancreas to stimulate insulin release.[9-11] In the present study Mucoadhesive Microspheres formulation was preferred 
over conventional tablet or capsule formulations, as it has several advanteges like it control the release pattern thus 
decreasing the dosing frequency by entrapping Repaglinide for the treatment of Diabetes Mellitus type II. 
 
2. Material and Methods  
Repaglinide were obtained as a gift sample, Liquid paraffin, carbopol, HPMC and span 80 were purchased from 
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Chemical Drug House, New Delhi. Other chemical and solvent were of Analytical Grade, 
2.1 Experimental work 
2.1.1 Formulation and characterization [12-14] 
Formulation of mucoadhesive microspheres of repaglinide:- 
 The mucoadhesive microspheres were prepared using emulsification solvent evaporation technique. The 
polymeric solution was prepared by dissolving carbopol and HPMC in distilled water. The drug was dispersed in the 
polymeric solution forming the internal phase. The prepared drug and polymer solution was added drop wise by a syringe 
with a needle gauge 22 to liquid paraffin (external phase) containing span 80(%v/v) and was emulsified by stirring at 500 
rpm. The stirring was continued at temperature 80
0
c until the polymer solvent was evaporated. The produced microspheres 
were decanted and washed 5 times with n –hexane and dried overnight. As shown in Table no.1. 
Table no. 1- Different Formulation of Mic rospheres. 
S.N. 
Formulation 
code 
HPMC K4m + 
Carbopol (w/v) 
HPMC K15m + 
Carbopol (w/v) 
HPMC K100m + 
Carbopol (w/v) 
Liquid paraffin 
(ml) 
Span 80 
(%) 
Stirring 
speed (rpm) 
1.  F-1 1:1 - - 200 0.5 500 
2.  F-2 1:2 - - 200 1.0 500 
3.  F-3 1:3 - - 200 1.5 500 
4.  F-4 - 1:1 - 200 0.5 500 
5.  F-5 - 1:2 - 200 1.0 500 
6.  F-6 - 1:3 - 200 1.5 500 
7.  F-7 - - 1:1 200 0.5 500 
8.  F-8 - - 1:2 200 1.0 500 
9.  F-9 - - 1:3 100 1.5 500 
2.1.2 Characterization of Mucoadhesive Microspheres 
Various characterization parameters were performed to study the particle size, mucoadhesivity, production yield, 
tapped density, bulk density, swelling index, in-vitro drug release of the prepared microsphere formulations. 
1. Particle Size Analysis 
Particle size was determined by optical microscope. Microsphere was examined on an optical microscope by using 
calibrated ocular micrometer and determined particle size of every formulation. The mean particle size was calculated by 
measuring nearly 200 particles of each formulation. Image of microspheres taken from Leica DM 1000 microscope are 
given blow. 
 
       
Fig 1: Microspheres Image from Leica DM 1000 Microscope 
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2. Production Yield: 
The production yield of microspheres of various batches using the weight of final product after drying with respect 
to initial total weight of the drug and polymer used for preparation of mucoadhesive microspheres and percent production 
yields are calculated as per the formula mentioned below.As shown in Table No.3 
% Production Yield =
Actual weight of microspheres
Total weight of exipients and drug
X100 
3. Determination of Bulk Density, Tapped Density and Compressibility Index.  
A) Bulk density: 
The bulk density determined by small quantity of microsphere (m) samples is carefully introduced into 10ml 
graduated cylinder, without compacting, read the unsettled apparent volume (V0) to nearest graduated unit. Calculate the 
bulk density in g/ml by the formula. 
Bulk density =
Mass of microspheres (m)
Initial volume (Vo)
 
B) Tapped density :- 
Tapped density determined by taking small quantity of microsphere sample  carefully introduced into 10 ml 
graduated cylinder. Cylinder was dropped at 2 sec. intervals on hard wood surface 100 times from height 1 inch. Tapped 
density of each sample was obtained by dividing weight of sample in gm. By final tapped volume in cm
3
 of sample contain 
in cylinder.As shown in Table No.4 
Tapped density =
Weight of microspheres
Volume of microspheres after tapping
 
C) Compressibility Index: 
It was determined by taking small quantity of microsphere sample in 10 ml measuring cylinder. The height of the 
sample was measured before and after tapping. 
V0: Unsettled apparent volume 
 Vf: Final tapped volume.           
Compressibility index =
 Vo − Vf 
𝑉𝑜
x 100 
4. Determination of Swelling Index of Microspheres 
For estimating the swelling index, weighed 100 mg of microspheres were allowed to swell in 0.1 N HCL for 24 h. 
The excess surface adhered liquid drops were removed by blotting and swollen microspheres were weighed by using 
microbalance. The degree of swelling was calculated by the following formula. As shown in Table No.5 
Swelling index =
Final weight − Initial weight
Final weight
 
5. Mucoadhesivity of Microspheres  
The mucoadhesive properties of the microspheres were evaluated in PBS 7.4. A 2x2-cm piece of got stomach 
mucosa was tied onto a glass slide (3x1-inch) using thread. Microspheres were spread (100) onto the wet, tissue specimen, 
and the prepared slide was hung onto one of the groves of a USP tablet disintegrating test apparatus. The disintegrating test 
apparatus was operated such that the tissue specimen was given regular up and down movements in a beaker containing the 
0.1N HCL (pH 1.2). At hourly intervals up to 6 hours, the number of microspheres still adhering onto the tissue was 
counted. Percent mucoadhesion was calculated by the following formula. As shown in Table No.6 
%  Mucoadhesion  =
No. of microspheres remains on stomach mucosa 
No. of microspheres applied on stomach mucosa
X100 
6. Determination of Entrapment Efficiency 
Entrapment Efficiency was determined by 100mg of dried microspheres were crushed using pestle and mortar. 
After that microspheres were placed in 100ml 0.1 N HCL   (pH 1.2) and shaken for 1 hour at 37±0.5
0
 c. Sample was 
withdrawn and filtered to obtain clear solution and analyzed for drug content spectrophotometrically at 247nm. As shown in 
Table No.7                                          
Entrapment Efficiency =
Calculated drug content     
Theoretical  drug content 
X100 
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7. In-Vitro Release Study:   
The in vitro dissolution studies were performed at three different pH values: (i) 1.2 pH (0.1N HCL) and  (ii) 7.4 
pH (PBS). In vitro drug release studies were carried out using US paddle type- II dissolution apparatus at 37± 0.5 C with 
constant stirring rate of 50 rpm. Mucoadhesive microspheres of repaglinide were used for the test. An accurately weighed 
sample was suspended in dissolution media consisting 900 ml of 0.1 N (pH 1.2) HCl and dissolution was carried out for 2 
h. The dissolution medium was then replaced with pH 7.4 phosphate buffer (900 ml) and drug release study was carried out 
for further 10h. A sample volume of 5 ml was withdrawn from each dissolution vessel at regular intervals and replaced with 
equal volume of fresh dissolution medium. The sample was filtered through Whatman filter paper and analyzed 
spectrophotometrically at 247 nm. As shown in Figure No.2 
8. Drug release kinetics: 
 The drug release kinetics was studied by various kinetic models such as zero order, first order, Higuchi 
model and Koresmeyer peppas release kinetics. As shown in Table No.8 
 
3. Result and Discussion 
3.1 Particle Size Analysis 
Particle size of microspheres prepared with HPMC K4m and different concentration of carbopol and span 80 (F1-
F3) was found to be in the range of 218-247µm; while range of particle size prepared with HPMC K15m and different 
carbopol and span 80 concentration (F4-F6) was found to be 375- 480µm and  the particle size of HPMC K100m and 
different carbopol and span 80 concentration (F7-F9) was found to be 326-590µm. The viscosity of surfactant and polymer 
in medium results in increasing particle size. 
The mean particle size of mucoadhesive microsphere was found in the following range as shown in Table – 
Table No.2– Mean Particle Size of Mucoadhesive Microspheres 
S. No. Formulation Average  Particle size in (μm) 
1 F -1 216 
2 F -2 241 
3 F -3 247 
4 F -4 375 
5 F -5 462 
6 F -6 480 
7 F -7 326 
8 F -8 496 
9 F -9 590 
2. Production Yield: 
Production yield of microspheres prepared with HPMC K4m and different concentration of carbopol and span 80 
concentration (F1-F3) was found to be in the range of 75-81%; while range of production yield of microspheres prepared 
using HPMC K15m with different carbopol and span 80 concentration (F4-F6) was found to be 68-79% and production 
yield of microspheres prepared with using HPMC K100m with different carbopol and span 80 concentration (F7-F9) was 
found to be 72-80% as shown in Table. 
Table No.3- Production Yield of Mucoadhesive Microspheres of Repaglinde 
S. No. Formulation % Production Yield 
1 F -1 75 
2 F -2 79 
3 F -3 81 
4 F -4 68 
5 F -5 71 
6 F -6 79 
7 F -7 72 
8 F -8 79 
9 F -9 80 
4. Bulk Density, Tapped Density and Compressibility Index: 
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A) Bulk Density: 
The bulk density of prepared microspheres with HPMC K4m and different concentration of carbopol and span 80 
concentration  (F1-F3) was found to be in the range of  0.2957-0.3681 gm/cm
3
; while range of bulk density of microspheres 
prepared with HPMC K15m and different carbopol and span 80 concentration (F4-F6)  was found to be 0.3090-0.3726 
gm/cm
3
;
 
and bulk density of microspheres prepared with HPMC K100m and different carbopol and span 80 concentration 
(F7-F9) found to be 0.300-0.3800 gm/cm
3
. 
B) Tapped Density: 
The tapped density of microspheres prepared with HPMC K4m and different concentration of carbopol and span 
80 concentration (F1-F3) was found to be in the range of 0.351-0.4263 gm/cm
3
; while range of tapped density of 
microspheres prepared with HPMC K15m and different carbopol and span 80 concentration (F4-F6) was found to be 0.377-
0.4176 gm/cm
3
 and tapped density of prepared microspheres with HPMC K100m and different carbopol and span 80 
concentration (F7-F9) was found to be 0.360-0.444 gm/cm
3
 
C) Compressibility Index: 
The Compressibility index of micrspheres prepared with HPMC K4m and different concentration of carbopol and 
span 80 concentration (F1-F3) was found to be in the  range of 13.636-16.667 %; while range of Compressibility index of 
microspheres prepared with HPMC K15m and different carbopol and span 80 concentration (F4-F6)  was found to be 
10.526-18.182 % and Compressibility index of microspheres prepared with HPMC K100m and different carbopol and span 
80 concentration (F7-f9) found to be 0.833-16.667 %. 
Table No.4– Bulk and tapped density of different formulations 
Sr. No. Formulation 
code 
Bulk density(gm/cm
3
) Tapped density 
(gm/cm
3
) 
Compressibility 
index 
1 F-1 0.3125 0.375 16.667 
2 F -2 0.2957 0.351 15.789 
3 F -3 0.3681 0.4263 13.636 
4 F -4 0.3090 0.377 18.182 
5 F -5 0.340 0.3923 13.33 
6 F -6 0.3736 0.4176 10.526 
7 F-7 0.300 0.360 08.33 
8 F -8 0.3288 0.3946 16.667 
9 F-9 0.3809 0.444 14.286 
 
5. Swelling Index: 
Swelling property of microspheres prepared with using HPMC K4m and different concentration of carbopol and 
span 80 concentration (F1-F3) was found to be in range 72.40-82.63 %; while swelling property of microspheres prepared 
with HPMC K15m and different carbopol and span 80 concentration (F4-F6) was found to be 74.96-79.31 % and the 
swelling property of microspheres developed with HPMC K100m and different carbopol and span 80 concentration (F7-F9) 
was found to be 69.97-80.19 %.  
Table No. 5- Swelling index of Mucoadhesive Microspheres: 
S. No Formulation code Swelling index (%) 
1.  F-1 82.63 
2.  F-2 76.31 
3.  F-3 72.40 
4.  F-4 79.31 
5.  F-5 77.81 
6.  F-6 74.96 
7.  F-7 80.19 
8.  F-8 73.87 
9.  F-9 69.97 
 
6. Mucoadhesivity of Microspheres:  
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Mucoadhesivity of microspheres prepared with using HPMC K4m and different concentration of carbopol and 
span 80 concentration (F1-F3) was found to be in the range of 76-84%; while mucoadhesivity of microspheres prepared with 
HPMC K15m and different carbopol and span 80 concentration (F4-F6) was found to be 72-80 % and the mucoadhesivity of 
microspheres developed with HPMC K100m and different carbopol and span 80 concentration (F7-F9) was found to be 69-
79 %. 
Table No. 6- Mucoadhesivity of Microspheres 
Time in (hr) Formulation code Mucoadhesivity in (%) 
1.  F-1 76 
2.  F-2 79 
3.  F-3 84 
4.  F-4 80 
5.  F-5 75 
6.  F-6 72 
7.  F-7 77 
8.  F-8 73 
9.  F-9 69 
 
7. Drug Entrapment: 
Entrapment efficiency of microspheres prepared with using HPMC K4m and different concentration of carbopol 
and span 80 concentration (F1-F3) was found to be in the range of 71-82 %; while entrapment efficiency of microspheres 
prepared with HPMC K15m and different carbopol and span 80 concentration (F4-F6) was found to be 60-76 % and the 
entrapment efficiency of microspheres developed with HPMC K100m and different carbopol and span 80 concentration 
(F7-F9) was found to be 75-86 %.  
 
Table No.7- Drug Entrapment Efficiency 
Sr. No. Formulation Entrapment Efficiency (%) 
1 F-1 71 
2 F -2 79 
3 F -3 82 
4 F -4 60 
5 F -5 65 
6 F -6 76 
7 F-7 75 
8 F -8 81 
9 F-9 86 
8. In-Vitro Release Study: 
 In vitro drug release study of repaglinide loaded mucoadhesive microspheres of optimized formulation of F3 was 
performed in 0.1 N HCL for inital 2 hour and PBS 7.4 pH for remaining 10 hour. The sizes of microspheres of F3 was small 
at low polymer concentration and have a larger surface area exposed to dissolution medium, giving rise to faster drug 
release. The production yield of F3 was 81 % which gives a greater total mass of microspheres as compare to other 
formulation which resulted in increased surface area of this batch releasing more drug release per unit time. The release of 
repaglinide was not likely to be dissolution controlled mechenism because repaglinide is water insoluble.  
 The drug release could be attributed to the diffusion of repaglinide from the mucoadhesive microspheres through 
the pore and channels on and close to the surface of the microspheres. 
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Figure No. 2: % Cumulative drug release of microspheres in 7.4 pH PBS 
Analysis of drug release data: 
 The data obtained for in vitro release where fitted into equations for the zero order, first order, Higuchi and 
peppas release model. The interpretation of data was based on the value of the resulting regression coefficient. 
 The zero order rate describe the system where the drug release rate is independent of its concentration graph-3 
shows the cumulative amount of drug release Vs time for zero order kinetic. The first order rate describes the release from 
system where the release rate is concentration dependent, which is shown in graph-4. The Higuchi model explain the 
release of drug from and insoluble matrix as a square root of time dependent process based on fickian diffusion graph-5  
illustrate Higuchi release model. 
 The calculated regression coefficient for zero order, first order, Higuchi and peppas was shown in table no 8. It 
was found that the in vitro drug release of repaglinide mucoadhesive microspheres was best explained by Higuchi as the 
plot showed the highest linearity. Therfore the release seems to fit the Higuchi’s model. 
To determine the exact mechanism of drug release, the data were fitted according to Korsemeyer-peppas release exponent n 
for the optimized formulation was 0.586 indicating release by fickian diffusion. 
 From the value of r
2
 obtained as shown  below in the table it was found that the maximum r
2 
value is shown in 
Higuchi release kinetics. Thus, the optimizied formulation followed the Higuchi release kinetics i.e. diffusion controlled 
release system. 
Table No.8: Regression value of formulation F-3 for different Release Kinetics Models 
S. No. r
2
 Kinetic model 
1 0.948 Zero order 
2 0.985 First order 
3 0.992 Higuchi model 
4 0.991 Peppas model 
DSC: 
 DSC of pure drug Repaglinide, polymer HPMC, Carbopol, Physical Mixture of drug and excipients and of 
formulation was performed. The DSC thermogram of Repaglinide showed a sharp endothermic peak at 131.92
0
 C. HPMC 
(K100m) exhibits a broad endotherm at 147.18
0
C. HPMC (K15m) shows a sharp endothermic peak at 106.58
0
C.HPMC 
(K4m) decomposes at 161.7
0
C.carbopol shows two peak out of which one is broad endothermic at  260.47
0
C and second 
may be due to H-Bonding.the physical mixture shows two endothermic and two exothermic peaks.the drug repaglinide in 
the physical mixture exhibits a sharp endotherm at 135.60
0
C. the DSC of F-3 shows 4 peaks out of which two are 
endothermic and two are exothermic. 
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Fig 3: The DSC of pure Repaglinide 
 
 
Fig 4: The DSC of hpmc K100m 
 
Fig 5: DSC of HPMC K15m 
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Fig 6 DSC of HPMC K4m 
 
 
Fig 7 The DSC of carbopol 934 
 
 
Fig 8 HPMC and Repaglinide + carbopol are shown in the fig. 
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Fig 9 DSC of microspheres of repaglinide   
  
4. Conclusion 
Mucoadhesive microspheres are prepared with various polymer HPMC (K4m, K15m, K100m), Carbopol 
successfully by the emulsification solvent evaporation technique. The amount of drug released from microspheres could be 
enhanced. In-vitro data obtained from mucoadhesive microspheres of Repaglinide showed optimum particle size, excellent 
mucoadhesivity, sufficient entrapment efficiency, good production yield, good swelling property and prolonged drug 
release. Microspheres of different size and drug content could be obtained by varying the formulation variables, thus the 
prepared mucoadhesive microspheres may prove to be potential candidates for the treatment of diabetes mellitus type II as 
a controlled drug delivery system.  
The formulations were evaluated for various micromeritics and characteristic studies. It increases the 
bioavailability of dosage form with prolong effect, hence improves the patients compliances.   
The designed Formulation F3 adheres in the stomach and prolongs the gastric residence time (GRT) consequently, 
providing controlled action. In addition, mucoadhesive microspheres enabled increased drug absorption rate, as it retained 
in the stomach and arrived at the absorption site. The developed formulation overcomes the drawbacks and limitations of 
conventional preparations. Therefore mucoadhesive microsphere will be possibly beneficial for controlled action.   
 
Acknowledgement  
Author is thankful to the Head of Department Dr A.K Pathak for providing facility to conduct the research work, 
Author is also thankful to Dr A.K Mishra for Guidance. 
 
References 
[1] Vyas SP, Khar RK, Controlled Drug Delivery Concept & Advances. 1st edition:vallabh prakashan; 2002  .p.174-180. 
[2] Jain S K, Awasthi AM, Jain NK, Agrawal GP.Calcium silicate based microspheres of repaglinide for gastroretention 
floating drug delivery: Preparation and in-vitro charectarization. J Cont Rel 2005; 107: 300– 309. 
[3] Kannan K, Karar PK, Manavalan R. Formulation and evaluation of sustained release Microspheres of Acetazolamide 
by solvent evaporation technique. J Pharm Sci & Res 2009; 1: 36-39. 
[4] Shaikh R, Raghu R T, Garland M, Donnelley R. Mucoadhesive Drug Delivery Systems.PMC 2010; 13:19-20. 
[5] Ghosh A, Nayak U K, Rout P. Preparation and Evaluation and in-vitro in vivo correlation (IVIVC ) study of lamivudind 
loaded microspheres  Res J Pharm And Tech  2008;1:87-89. 
[6] Garg R, Gupta GD. Progress in Controlled Gastroretentive Drug Delivery. Trop J Pharm Res 2008; 7: 3. 
[7] Longer MA, Robinson JR. Remington Pharmaceutical Science. 18th ed. Eastern Pennsylvania: Mack Publishing 
Company; 1990.p. 1676-1686. 
[8] Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and 
projections for 2030. Diabetes Care 2004:27; 1047-53. 
International Journal of Advances in Pharmaceutics 4 (5) 2015                                                                                   82 
 
 
 
[9] Tripathi KD. Essential of Medical Pharmacology. 6th edition: JP Brother and Medical Publisher and pvt ltd; 
2008.p.254-274. 
[10] Godman gilman’s The pharmacological basis of therapeutics.10th edition .USA: Mcgraw hill Medical Publishing; 2001 
.p. 1704-1705. 
[11] Clarke's .Analysis of Drugs and Poisons.3rd Edition: Pharmaceutical Press; 2005. 
[12] Yellanki KS, Singh J, Syed AJ. Design and Characterization of Amoxycillin Trihydrate Mucoadhesive Microspheres 
for prolonged gastric retention 2010:2; 112-114. 
[13] Vyas SP, Khar RK, Controlled Drug Delivery Concept & Advances. 1st edition:vallabh prakashan; 2002 p. 419-424. 
[14] Wise DL.Handbook of pharmaceutical controlled release technology. 2
nd
 edition; 2006. p. 332. 
